Rebecca Tan
ABOUT
Rebecca did her PhD at the National University of Singapore where she studied how macrophages integrate multiple signals from the toll-like receptor system. She was formerly the editor-in-chief of Asian Scientist Magazine.
Stories by Rebecca Tan
Rapid, Rigorous And Robust: How Singapore Approved Its COVID-19 Vaccines
No shortcuts were taken in the COVID-19 vaccine review processes, says Professor John Lim, executive director of the Centre of Regulatory Excellence at Duke-NUS Medical School.
On The Cusp Of CRISPR
When Yoshizumi Ishino first encountered in 1986 the mysterious sequences that would later come to be known as CRISPR, he was as far away from the present day as he was to the discovery of the double helix. Here is the story of what has happened since then.
Mutation Making SARS-CoV-2 Milder Identified
The ∆382 mutation in the open reading frame 8 region of the SARS-CoV-2 genome leads to less severe infections and could possibly be used as a live attenuated vaccine.
Cultivating CRISPR For Crops
For gene editing technologies like CRISPR to make a positive impact on agriculture, they must be embraced by companies both big and small. Corteva Agriscience is encouraging open innovation to help bridge the gap.
COVID-19 Diagnostics Explained
Access to testing is essential for containing COVID-19, but the accuracy of the tests used also matters a great deal.
Follow The Money
Forget speed; 5G is really about transforming the way business is done, says Huawei’s chief technology officer Paul Scanlan.
Students Take The Stage
Given time, training and resources, students can achieve amazing feats, as demonstrated by the teams taking part in the 2019 APAC HPC-AI Competition.
From Beer To Bispecifics And Beyond
Kiran Mazumdar-Shaw, chairman and managing director of Biocon, shares her thoughts on Asia’s growing role in biotech R&D.